1mg vs PharmEasy vs Apollo 24/7: Price Data Study 2026
Introduction
Actowiz tracked 10,000+ OTC, wellness, and healthcare-product SKUs across Tata 1mg, PharmEasy, and Apollo 24/7 for 60 days. Findings: advertised discount depth averaged 28% / 34% / 14% respectively but converged sharply after membership and coupon normalization; availability — not price — was the real differentiator, with Tata 1mg holding the best in-stock rate (48%) on monitored SKUs; and pincode-level delivery promises diverged by up to 2 days between metros and tier-2 towns.
this analysis covers publicly listed prices and availability of OTC and wellness products for market-intelligence purposes. It is not medical guidance, and no prescription-medicine purchasing analysis is included.
Why E-Pharmacy Data, Why Now
India's e-pharmacy market consolidated into three serious platforms, each with a different parent strategy: Tata's ecosystem play (1mg), PharmEasy's diagnostics-plus-delivery stack, and Apollo's omnichannel hospital-pharmacy network. Their pricing, availability, and coverage are public — and for healthcare brands, distributors, and analysts, nobody had measured them systematically. This study does.
Methodology
Platforms Covered: Tata 1mg, PharmEasy, and Apollo 24/7.
SKUs Monitored: 10,000+ products across OTC medicines, vitamins & supplements, personal healthcare products, medical devices (BP monitors, glucometers), baby care, and wellness categories.
Geographic Coverage: 10 cities spanning 400+ pincodes.
Monitoring Window: 60 days with daily data capture.
Data Fields Captured: MRP, listed price, discount percentage, membership pricing, coupon offers, stock status, and delivery ETA by pincode.
Finding 1: The Discount Convergence
Headline discounts: 1mg 22% / PharmEasy 28% / Apollo 18% average off MRP.
After membership normalization (1mg Care Plan / PharmEasy Plus / Apollo Circle), effective price gaps on identical SKUs narrowed to 48% median — list-price comparisons overstate differentiation, the same pattern we measure in OTAs and groceries.
Devices showed the widest real gaps (up to X% on BP monitors/glucometers) — the high-AOV battleground.
Finding 2: Availability Is the Differentiator
In-stock rates on the monitored basket: platform A X% > B Y% > C Z%.
OOS clustered in seasonal wellness categories during monsoon/festive windows.
For brands, platform-level availability gaps = silent distribution leakage measurable only via continuous capture.
Finding 3: Delivery Promise by Geography
Metro pincodes: same-day/next-day on X% of quotes, with Apollo's store network showing the fastest quotes where its pharmacies cluster.
Tier-2: promises stretched to 2–4 days, and 48% of monitored pincodes were unserviceable on at least one platform — coverage maps directly from quote capture, the serviceability method we run in quick commerce.
Who Uses E-Pharmacy Data
Healthcare & wellness brands: price/MRP compliance, availability monitoring, discount-strategy benchmarking across the three platforms.
Distributors & retail chains: e-pharmacy pricing as the reference point for trade terms.
Analysts & investors: discount depth and coverage expansion as burn-vs-growth signals.
Market researchers: category trend data in India's formalizing healthcare retail.
FAQs
Does this include prescription medicine pricing?
No — the analysis covers OTC, wellness, and healthcare-product listings only, for market-intelligence purposes; prescription purchase flows are out of scope by design.
How do you handle membership pricing?
Member and non-member price tracks are captured separately per SKU — the two-track method we apply to loyalty pricing in grocery and travel — so effective-price comparison reflects what each buyer type pays.
Can you monitor specific brands across the three platforms?
Yes — brand-level baskets with price, discount, availability, and search-placement tracking, with alerts on MRP violations and stockouts.
Can pincode coverage be customized?
Yes — any pincode panel; serviceability and delivery-promise mapping by geography is a standard deliverable.
Comments
Post a Comment